|
Market Cap (20-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 30 July 2021, 10:06. The announcement is marked as price sensitive, and is 7 page(s) in length and 263.47kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.018% short sold according to ASIC data. It was ranked the 580th most shorted stock on the ASX. It is now ranked as the 544th most shorted stock on the ASX with 0.017% of total shares short sold as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 30 July 2021, 10:06 |
| US Patent Office issues Notice of Allowance for NRGBiotic | 27 July 2021, 9:03 |
| Medlab executes Master Services Agreement with WEP Clinical | 19 July 2021, 9:01 |
| Australian Ethics Grants Approval for NanaBis PIII AUS Sites | 12 July 2021, 9:28 |
You must be logged in to post a reply.
Medlab Clinical 